Toripalimab Plus Chemotherapy as First-Line Therapy for Extensive-Stage SCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial
JAMA Oncol 2024 Nov 14;[EPub Ahead of Print], Y Cheng, W Zhang, L Wu, C Zhou, D Wang, B Xia, M Bi, X Fu, C Li, D Lv, Y Zhao, G Chen, T Yi, J Huang, M Li, R Yang, X Huang, Y Wang, M Zhang, Y Pan, Y Sun, S Hu, X Zhang, M Zhou, J Fang, F Jin, Y Liu, Y Li, Z Zhang, J Hu, L Liu, R Wang, Y Li, K Gu, C Ding, Q Fan, G Zhang, Y Chen, L Jiang, WE Zheng, S Chen, C Huang, Z Han, H Yang, J Wang, B Wang, H Wu, Y Bao, M Li, X Luo, S Gu, W Yu, K Xu, S Zhang, J YuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.